|
CDC25C expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67044156285101E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.12830000184883E-08 |
| Normal-vs-Stage2 |
7.116300E-02 |
| Normal-vs-Stage3 |
2.383000E-03 |
| Normal-vs-Stage4 |
1.743720E-02 |
| Stage1-vs-Stage2 |
4.961400E-01 |
| Stage1-vs-Stage3 |
1.176430E-02 |
| Stage1-vs-Stage4 |
5.055800E-02 |
| Stage2-vs-Stage3 |
4.456300E-02 |
| Stage2-vs-Stage4 |
7.197900E-02 |
| Stage3-vs-Stage4 |
8.171200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65945035490722E-12 |
| Normal-vs-AfricanAmerican |
4.810700E-04 |
| Normal-vs-Asian |
1.594030E-01 |
| Caucasian-vs-AfricanAmerican |
7.907600E-01 |
| Caucasian-vs-Asian |
2.151000E-01 |
| AfricanAmerican-vs-Asian |
2.111600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97210003882731E-09 |
| Normal-vs-Female |
1.93889999999808E-06 |
| Male-vs-Female |
1.355950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.178200E-04 |
| Normal-vs-Extreme_Weight |
2.47569997835484E-09 |
| Normal-vs-Obese |
1.65100000004692E-06 |
| Normal-vs-Extreme_Obese |
7.510300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.318200E-02 |
| Normal_Weight-vs-Obese |
4.945600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.721000E-03 |
| Extreme_Weight-vs-Obese |
9.588100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.480900E-03 |
| Obese-vs-Extreme_Obese |
6.596400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.602480E-02 |
| Normal-vs-Age(41-60Yrs) |
1.16160003837962E-09 |
| Normal-vs-Age(61-80Yrs) |
3.66550000000521E-05 |
| Normal-vs-Age(81-100Yrs) |
1.691640E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.844600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.891250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.974300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.389000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.699600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.772600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.93300930817486E-12 |
| Normal-VS-Type2 PRCC |
1.809940E-04 |
| Normal-VS-KIRP CIMP |
7.257400E-03 |
| Normal-VS-Unclassified PRCC |
2.565600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.217300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.569700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.601800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.430440E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.070400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.494400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.199900E-03 |
| Normal-vs-N1 |
1.74753999999666E-05 |
| Normal-vs-N2 |
1.263590E-01 |
| N0-vs-N1 |
5.169800E-02 |
| N0-vs-N2 |
7.445000E-01 |
| N1-vs-N2 |
4.780600E-01 |
|
|
